Engineered for surgical precision, rapid osseointegration, and strict international compliance. Directly exported to hospitals and medical procurement centers in Riyadh.
In modern reconstructive orthopedics, cranio-maxillofacial surgery, and revision arthroplasty, the requirement for biological bone graft substitutes has shifted from passive space-fillers to active, osteoconductive scaffolds. Synthetic Hydroxyapatite (HA) represents the gold standard in non-allogenic graft materials due to its crystallographic and chemical identity to natural human bone mineral. As a leading manufacturer and direct exporter serving hospital networks across Riyadh, our synthetic bone graft solutions are synthesized under strict high-temperature sintering processes that guarantee a stoichiometric Calcium-to-Phosphorus ($Ca/P$) ratio of exactly 1.67.
Unlike un-sintered or non-pure calcium phosphate ceramics, high-purity Hydroxyapatite provides predictable biomechanical stability under physiological loads. The material's architecture is engineered with a dual-porosity matrix:
Facilitates rapid vascularization (angiogenesis), cell migration, and deep osteon formation throughout the core of the graft matrix.
Promotes capillary fluid absorption, protein adsorption (BMP-2, Osteocalcin), and cellular attachment at the microscopic interface.
Exhibits crystalline phase purity exceeds 95% under X-ray Diffraction (XRD) analysis, ensuring minimal systemic immunological response.
The healthcare sector in Riyadh, driven by national modernization programs under Saudi Vision 2030, demands uncompromising medical device reliability. Hospitals such as King Fahad Medical City (KFMC), King Faisal Specialist Hospital & Research Centre (KFSH&RC), and leading private healthcare groups (such as Dr. Sulaiman Al Habib Medical Group and Saudi German Health) encounter specific patient demographic profiles that rely heavily on synthetic bone graft substitutes and precision orthopedic hardware.
With an increasing prevalence of severe osteoarthritis and secondary revision surgeries in the Central Province of Saudi Arabia, orthopedic surgeons frequently encounter massive bone loss in femoral and tibial segments. Our synthetic hydroxyapatite porous granules and structural blocks are utilized to fill metaphyseal defects, providing a non-compressible scaffold that prevents implant subsidence when paired with CoCrMo or Titanium revision joint prostheses.
Riyadh’s major trauma centers require immediate, off-the-shelf availability of sterile biomaterials for open fracture management and non-union defect repairs. Synthetic HA eliminates the risk of donor-site morbidity associated with autografts and avoids the pathogen transmission risks inherent in imported human allografts.
In degenerative lumbar spine surgery, synthetic HA granules mixed with autologous bone marrow aspirate (BMA) serve as an effective graft extender inside PEEK cages or titanium spinal mesh structures, delivering high fusion rates without donor site complications.
Within specialized dental centers across Riyadh, micro-granule HA forms (0.25–1.0 mm) are extensively used for sinus floor elevations, guided bone regeneration (GBR), and post-extraction socket preservation prior to dental implant placement.
To assist clinical procurement committees in Riyadh with objective evaluation, the following matrix compares Synthetic Hydroxyapatite against traditional biomaterial options:
| Biomaterial Parameter | Synthetic Hydroxyapatite (HA) | Beta-Tricalcium Phosphate (β-TCP) | Human Demineralized Bone (DBM) | Biphasic Calcium Phosphate (BCP) |
|---|---|---|---|---|
| Chemical Composition | $Ca_{10}(PO_4)_6(OH)_2$ | $Ca_3(PO_4)_2$ | Allogenic Collagen Matrix | HA + β-TCP Blend (60/40) |
| In-Vivo Resorption Rate | Slow & Stable (12–36 months) | Rapid (3–6 months) | Variable (User Dependent) | Moderate (6–18 months) |
| Compressive Strength | High (30 – 130 MPa) | Moderate (5 – 15 MPa) | Low (Negligible structural strength) | Moderate to High (20 – 80 MPa) |
| Immunogenicity & Infection Risk | Zero Risk (Synthetic Origin) | Zero Risk (Synthetic Origin) | Low Potential Disease Vector | Zero Risk (Synthetic Origin) |
| Shelf Life & Storage | 5 Years (Ambient Temperature) | 5 Years (Ambient Temperature) | Strict Temperature Control Needed | 5 Years (Ambient Temperature) |
| SFDA Import Regulatory Ease | Streamlined (Class III Device) | Streamlined (Class III Device) | Complex Tissue Clearance | Streamlined (Class III Device) |
Under the Saudi Vision 2030 Healthcare Transformation Program, Saudi Arabia is privatizing hospital operations, expanding local infrastructure, and demanding higher standards of medical device traceability. The Kingdom’s medical device market is regulated strictly by the Saudi Food and Drug Authority (SFDA). For foreign manufacturers exporting to Riyadh, establishing direct factory relationships with validated ISO 13485 cleanroom infrastructure is critical.
Our Hydroxyapatite products and accompanying surgical instruments comply fully with SFDA Medical Device Marketing Authorization (MDMA) technical dossier requirements.
Designed to meet the technical specification criteria of National Unified Procurement Company (NUPCO) tenders supplying Ministry of Health (MOH) and Military hospitals.
Packaged in dual gamma-sterilized blisters within moisture-impermeable aluminum pouches, guaranteed to withstand high heat and humidity variations during transport.
Established in 1994 in Vadodara, Gujarat, India, Bharucha Associates (operating globally via Tlamelo Medical) brings over 30 years of engineering expertise in orthopedic device fabrication, surgical power drills, micro-instrumentation, and synthetic bone graft manufacturing.
Our global supply chain reaches more than 40 countries spanning the Middle East, Southeast Asia, Latin America, and Africa. By combining high-precision manufacturing, proprietary sintering technology, and competitive factory-direct pricing, we provide hospital procurement directors and medical equipment distributors in Riyadh with an unassailable supply chain advantage.
Partner with an established 30+ year manufacturer. Obtain CE & ISO validated synthetic bone grafts, prosthetic components, and surgical instrument kits direct from our export facility.
Get Catalog